To the Editor—Burgos et al. conclude that isoniazid-resistant strains are less likely than drug-susceptible strains to result in secondary cases [1]. Although Burgos et al., with the excellent database available in San Francisco, are well placed to study this subject, the method of analysis that they have used seems biased.